Sort
59,101 grants matching “hypertension”
Genetics of Coronary Artery Disease in Alaska Natives
$566,398Jason G Umans · Medstar Health Research Institute · U01 · FY2009 · HL
The Health Impacts of the MyGoals Randomized Controlled Trial
$566,385Peter A Muennig · Columbia University Health Sciences · R56 · FY2019 · AG
Impact of nurse case management on diabetes co-morbidity
$566,377Robert A Gabbay · Pennsylvania State Univ Hershey Med Ctr · R18 · FY2009 · DK
The Impact of Structural Racism and Discrimination (SRD) on Mechanisms of the Native American Pain Disparity
$566,375Jamie Lynn Rhudy · University Of Tulsa · R01 · FY2023 · AT
A Spatially Resolved Molecular Atlas of Human Endothelium
$566,374Long Cai · California Institute Of Technology · U54 · FY2018 · HL
Immune Modulation in Hypertension
$566,364Meenakshi Swaminathan Madhur · Indiana University Indianapolis · R01 · FY2025 · HL
Regulation of lymphatic muscle cell function by store operated calcium entry signaling
$566,328Scott D. Zawieja · University Of Missouri-Columbia · R01 · FY2025 · HL
Dietary Patterns and Risk of Cardiovascular Disease
$566,328Frank B Hu · Harvard School Of Public Health · R01 · FY2016 · HL
Atrial Fibrillation: Incidence, Risk Factors, and Genetics
$566,313Susan Heckbert · University Of Washington · R01 · FY2010 · HL
Gestational PFAS Mixture Exposures, Longitudinal Metabolomic Profiles, and Adolescent Cardiometabolic Health
$566,298Joseph M Braun · Brown University · R01 · FY2023 · ES
Regulation of lipid metabolism in pulmonary Type 2 cells
$566,268Itsaso Garcia-Arcos · Suny Downstate Medical Center · R01 · FY2023 · HL
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS ANDTHERAPEUTIC ADVANCES (VITA): BIOENGINEEREDGRAFTS FOR PERIPHERAL VASCULAR DISEASE FOR BASEPERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014
$566,202Michael Conte · Humacyte, Inc. · N01 · FY2015 · HL
Fibrinogen and Factor XIII in Venous Thromboembolism
$566,163Alisa S Wolberg · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Fibrinogen and Factor XIII in Venous Thromboembolism
$566,163Alisa S Wolberg · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Fibrinogen and Factor XIII in Venous Thromboembolism
$566,163Alisa S Wolberg · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Development of a therapeutic anti-marinobufagenin antibody
$566,150Alexei Bagrov · National Institute On Aging · ZIA · FY2014 · AG
Aging and interaction of natriuretic factors on renal and vascular sodium pump
$566,150Alexei Bagrov · National Institute On Aging · ZIA · FY2014 · AG
Molecular Mechanisms of Exfoliation Glaucoma
$566,148Michael A Hauser · Duke University · R01 · FY2019 · EY
Improving Adherence and Intensification of Medications Among Diabetes Patients
$566,140Eve A Kerr · University Of Michigan At Ann Arbor · R18 · FY2008 · DK
CARDIA-PLUS: A Life Course Investigation of Biopsychosocial Pathways to Bladder Health and Lower Urinary Tract Symptoms
$566,131Sonya S Brady · University Of Minnesota · R01 · FY2024 · DK
Pathogenesis of Cardiopulmonary Fibrosis Associated with Heart Failure in the Elderly
$566,131Krishna C Penumatsa · Tufts Medical Center · R01 · FY2023 · AG
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)
$566,044Josef Coresh · Johns Hopkins University · U01 · FY2012 · HL
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT
$566,039Patricia J Coon · Billings Clinic Foundation · R18 · FY2006 · DK
Core--Genomics
$566,021Howard J Jacob · Medical College Of Wisconsin · P01 · FY2009 · HL
Training in Translational Science and Cardiovascular Research
$566,018Nabil J. Alkayed · Oregon Health & Science University · T32 · FY2024 · HL